Abstract P5-13-04: A phase II neoadjuvant trial of MK-2206, an AKT inhibitor, in combination with anastrozole for clinical stage 2 or 3 PIK3CA mutant estrogen receptor positive HER... by Ma, CX, Suman, VJ, Goetz, M, Northfelt, D, Burkard, M, Ademuyiwa, F, Naughton, M, Margenthaler, J, Aft, R, Gray, R, Tavaarwerk, A, Wilke, L, Haddad, T, Moynihan, T, Loprinzi, C, Hieken, T, Hoog, J, Guo, Z, Han, J, Vij, K, Mardis, E, Sanati, S, Al-Kateb, H, Doyle, L, Erlichman, C, Ellis, MJ

Get full text